Cost-effectiveness of broadly neutralizing antibody prophylaxis for HIV-exposed infants in sub-Saharan African settings.

Caitlin M DugdaleOgochukwu UfioChristopher AlbaSallie R PermarLynda Stranix-ChibandaColeen K CunninghamGenevieve G FoudaLandon MyerMilton C WeinsteinValeriane LeroyElizabeth J McFarlandKenneth A FreedbergAndrea L Ciaranello

Published in: Journal of the International AIDS Society (2023)

At current efficacy and cost estimates, bNAb prophylaxis for HIV-exposed children in sub-Saharan African settings would be a cost-effective intervention to reduce vertical HIV transmission.

Keyphrases

antiretroviral therapy
hiv positive
hiv infected
hiv testing
human immunodeficiency virus
hepatitis c virus
hiv aids
men who have sex with men
randomized controlled trial
south africa
young adults
zika virus